Health chiefs must act now to allow millions of people to benefit from “statins for the brain”, scientists say.
Justin Bone detailed the days leading up to his arrest, describing taking drugs and wandering various parts of the city after ...
Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two experimental ...
A regulatory protein in astrocytes may explain how certain memories persist over time for learning and cognitive function.
With an increasingly aging global population and no available preventive treatments, Alzheimer's disease and related ...
Initially, unadjusted analyses suggested a slight increase in the risk of MCI or dementia among hypnotic users compared with ...
Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease. New research in ...
Bio-Hermes-002 is a collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and dementias WASHINGTON.
Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), today announced that ...
For more than a century, Alzheimer’s disease has been considered a condition that cannot be reversed. Doctors have focused on slowing the disease because they believed the damage to brain cells could ...
A drug that raises levels of histamine – the chemical that causes allergy symptoms – in the brain boosts our memory by around ...
A British start-up is sending a miniature laboratory into orbit to open a new frontier in the battle against Alzheimer’s disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results